The American Medical Group Association (AMGA) today recommended that CMS reverse its decision to forgo the 2021 application cycle for the Medicare Shared Savings Program (MSSP) and maintain the progression through levels of risk in the program.
Alexandria, VA—The American Medical Group Association (AMGA) today recommended that CMS reverse its decision to forgo the 2021 application cycle for the Medicare Shared Savings Program (MSSP) and maintain the progression through levels of risk in the program. While CMS has taken several steps to support health care providers during the coronavirus disease 2019 (COVID-19) public health emergency, the transition to value-based care should continue. Providers have adopted new care management strategies because of the pandemic, and the lessons learned will inform care delivery models in the future. Those providers that voluntarily wish to enter the MSSP should have an opportunity to do so.
“CMS has instituted a number of changes to support providers and their patients during the national public health emergency,” said AMGA President and CEO Jerry Penso, MD, MBA. “But the work to move our delivery system to one that prioritizes value needs to continue. We cannot afford to pause the progress that we have made in the transition to value-based care, and cancelling the 2021 application cycle for the MSSP will unnecessarily inhibit that transition.”
CMS’ interim final rule also provides those accountable care organizations (ACOs) participating in the BASIC track of the MSSP with an option to maintain their current risk level for an additional year. However, those ACOs that select this option will not advance to the next level of risk in sequential order. For example, a “Level B” ACO that selects to remain at Level B will move to Level D the following year, bypassing Level C. While AMGA supports the option for ACOs to remain in their current risk level, CMS should not then move them past a stage and into a more advanced risk level automatically. It is important that ACOs continue to assume additional risk incrementally.
The letter is available on the AMGA website.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Minimizing Terms for Toxicity Often Used in Multiple Myeloma Trials, Study Says
November 22nd 2023A cohort study of 65 clinical trials in multiple myeloma found that toxic effects are often described with subjective terminology that may not reflect adverse event rates reported in the studies.
Read More